Better Access Better Healthcare
We improve global healthcare through better access to medicine.
Abacus Medicine is firmly established among the market leaders in the European parallel distribution industry.
Originalis is a parallel distributor of medicine operating in Germany and Ireland.
Abacus Medicine Pharma Services works with Clinical Trial Supply, Commercial Partnerships and Unlicensed Medicines.
Pluripharm is a leading wholesaler in the Netherlands and offers a full line of medicines, medical devices and services to a range of customers.
We are innovative, dedicated
and we care.
The Abacus Medicine Group is built on a strong purpose. When we compete in the market, we help lower the prices on life-critical medicines so that they become more widely available.
The Abacus Medicine Group is a business. We operate commercially, and our activities provide jobs, careers and livelihoods for hundreds of people in dozens of countries.
But we are more than that. When we compete in the market, we help life-critical medicines become more widely available. This gives us a purpose beyond ourselves and is something we can be proud of.
CEO & majority shareholder
Packs sold in 2021
A career in the Abacus Medicine Group
Join a young, ambitious and diverse company.
We are always looking for new and dedicated colleagues.
Maria Addis appointed new Group Chief Financial Officer (Group CFO) of the Abacus Medicine Group. The current CFO of media group Watch Medier joins Abacus
Abacus Medicine contributes to savings of € 99.5 million for the Danish pharmaceutical market in 2021. A report published by The Danish Association of Parallel
Annual report 2021: The Abacus Medicine Group overcame challenging markets affected by COVID-19 to record high revenue growth. Revenue rose 42% to EUR 941 million